Annual Revenue
$9.30 M
-$68.34 M-88.02%
December 31, 2023
Summary
- As of February 12, 2025, BBIO annual revenue is $9.30 million, with the most recent change of -$68.34 million (-88.02%) on December 31, 2023.
- During the last 3 years, BBIO annual revenue has risen by +$1.05 million (+12.78%).
- BBIO annual revenue is now -88.02% below its all-time high of $77.65 million, reached on December 31, 2022.
Performance
BBIO Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$2.73 M
+$564.00 K+26.01%
September 30, 2024
Summary
- As of February 12, 2025, BBIO quarterly revenue is $2.73 million, with the most recent change of +$564.00 thousand (+26.01%) on September 30, 2024.
- Over the past year, BBIO quarterly revenue has increased by +$987.00 thousand (+56.56%).
- BBIO quarterly revenue is now -98.71% below its all-time high of $211.12 million, reached on March 31, 2024.
Performance
BBIO Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$217.76 M
-$1.36 M-0.62%
September 30, 2024
Summary
- As of February 12, 2025, BBIO TTM revenue is $217.76 million, with the most recent change of -$1.36 million (-0.62%) on September 30, 2024.
- Over the past year, BBIO TTM revenue has increased by +$208.46 million (+2240.80%).
- BBIO TTM revenue is now -0.62% below its all-time high of $219.12 million, reached on June 30, 2024.
Performance
BBIO TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
BBIO Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -88.0% | +56.6% | +2240.8% |
| 3 y3 years | +12.8% | +56.6% | +2240.8% |
| 5 y5 years | - | +56.6% | +2240.8% |
BBIO Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -88.0% | at low | -98.7% | +708.3% | -0.6% | +3737.3% |
| 5 y | 5-year | -88.0% | +12.8% | -98.7% | +2139.3% | -0.6% | +3737.3% |
| alltime | all time | -88.0% | +12.8% | -98.7% | +2139.3% | -0.6% | +3737.3% |
BridgeBio Pharma Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.73 M(+26.0%) | $217.76 M(-0.6%) |
| Jun 2024 | - | $2.17 M(-99.0%) | $219.12 M(+0.2%) |
| Mar 2024 | - | $211.12 M(>+9900.0%) | $218.60 M(+2249.7%) |
| Dec 2023 | $9.30 M(-88.0%) | $1.75 M(-57.3%) | $9.30 M(-1.3%) |
| Sep 2023 | - | $4.09 M(+149.3%) | $9.43 M(+66.1%) |
| Jun 2023 | - | $1.64 M(-10.1%) | $5.67 M(-92.7%) |
| Mar 2023 | - | $1.83 M(-2.4%) | $77.78 M(+0.2%) |
| Dec 2022 | $77.65 M | $1.87 M(+453.3%) | $77.65 M(-12.4%) |
| Sep 2022 | - | $338.00 K(-99.5%) | $88.66 M(-2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $73.75 M(+4253.4%) | $90.67 M(+27.8%) |
| Mar 2022 | - | $1.69 M(-86.9%) | $70.95 M(+1.8%) |
| Dec 2021 | $69.72 M(+745.1%) | $12.89 M(+449.7%) | $69.72 M(+22.4%) |
| Sep 2021 | - | $2.34 M(-95.7%) | $56.95 M(-9.2%) |
| Jun 2021 | - | $54.02 M(>+9900.0%) | $62.73 M(+620.2%) |
| Mar 2021 | - | $462.00 K(+278.7%) | $8.71 M(+5.6%) |
| Dec 2020 | $8.25 M(-79.7%) | $122.00 K(-98.5%) | $8.25 M(-62.4%) |
| Sep 2020 | - | $8.13 M(-41.2%) | $21.95 M(-45.9%) |
| Dec 2019 | $40.56 M | $13.82 M(-48.3%) | $40.56 M(+51.7%) |
| Sep 2019 | - | $26.74 M | $26.74 M |
FAQ
- What is BridgeBio Pharma annual revenue?
- What is the all time high annual revenue for BridgeBio Pharma?
- What is BridgeBio Pharma annual revenue year-on-year change?
- What is BridgeBio Pharma quarterly revenue?
- What is the all time high quarterly revenue for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly revenue year-on-year change?
- What is BridgeBio Pharma TTM revenue?
- What is the all time high TTM revenue for BridgeBio Pharma?
- What is BridgeBio Pharma TTM revenue year-on-year change?
What is BridgeBio Pharma annual revenue?
The current annual revenue of BBIO is $9.30 M
What is the all time high annual revenue for BridgeBio Pharma?
BridgeBio Pharma all-time high annual revenue is $77.65 M
What is BridgeBio Pharma annual revenue year-on-year change?
Over the past year, BBIO annual revenue has changed by -$68.34 M (-88.02%)
What is BridgeBio Pharma quarterly revenue?
The current quarterly revenue of BBIO is $2.73 M
What is the all time high quarterly revenue for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly revenue is $211.12 M
What is BridgeBio Pharma quarterly revenue year-on-year change?
Over the past year, BBIO quarterly revenue has changed by +$987.00 K (+56.56%)
What is BridgeBio Pharma TTM revenue?
The current TTM revenue of BBIO is $217.76 M
What is the all time high TTM revenue for BridgeBio Pharma?
BridgeBio Pharma all-time high TTM revenue is $219.12 M
What is BridgeBio Pharma TTM revenue year-on-year change?
Over the past year, BBIO TTM revenue has changed by +$208.46 M (+2240.80%)